MacDougall Donna M, Halperin Scott A
a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority , Halifax , Nova Scotia , Canada.
b School of Nursing, St. Francis Xavier University , Antigonish , Nova Scotia , Canada.
Hum Vaccin Immunother. 2016 Apr 2;12(4):857-65. doi: 10.1080/21645515.2015.1101524.
An increasing number of vaccines are recommended or are being developed for use during pregnancy to protect women, fetuses, and/or newborns. For vaccines that are already recommended, vaccine uptake is variable and well below desired target. We reviewed the literature related to factors that affect a healthcare provider's recommendation and a woman's willingness to be vaccinated during pregnancy.
A scoping review of published literature from 2005 to 2015 was undertaken and all relevant articles were abstracted, summarized, and organized thematically.
Barriers and facilitators were identified that either decreased or increased the likelihood of a healthcare provider offering and a pregnant woman accepting vaccination during pregnancy. Concern about the safety of vaccines given during pregnancy was the most often cited barrier among both the public and healthcare providers. Other barriers included doubt about the effectiveness of the vaccine, lack of knowledge about the burden of disease, and not feeling oneself to be at risk of the infection. Major facilitators for maternal immunization included specific safety information about the vaccine in pregnant women, strong national recommendations, and healthcare providers who both recommended and provided the vaccine to their patients. Systems barriers such as inadequate facilities and staffing, vaccine purchase and storage, and reimbursement for vaccination were also cited. Evidence-based interventions were few, and included text messaging reminders, chart reminders, and standing orders.
In order to have an effective vaccination program, improvements in the uptake of recommended vaccines during pregnancy are needed. A maternal immunization platform is required that normalizes vaccination practice among obstetrical care providers and is supported by basic and continuing education, communication strategy, and a broad range of research.
越来越多的疫苗被推荐用于孕期或正在研发用于孕期,以保护女性、胎儿和/或新生儿。对于已被推荐的疫苗,其接种率参差不齐,且远低于预期目标。我们回顾了与影响医疗保健提供者推荐以及女性孕期接种意愿的因素相关的文献。
对2005年至2015年发表的文献进行范围综述,所有相关文章均被提取、总结并按主题进行整理。
确定了阻碍因素和促进因素,这些因素分别降低或增加了医疗保健提供者在孕期提供疫苗以及孕妇接受疫苗接种的可能性。公众和医疗保健提供者中最常被提及的阻碍因素是对孕期接种疫苗安全性的担忧。其他阻碍因素包括对疫苗有效性的怀疑、对疾病负担缺乏了解以及不认为自己有感染风险。孕产妇免疫接种的主要促进因素包括关于孕妇接种疫苗的具体安全信息、强有力的国家推荐以及既推荐又为患者提供疫苗的医疗保健提供者。还提到了诸如设施和人员不足、疫苗采购和储存以及疫苗接种报销等系统障碍。基于证据的干预措施很少,包括短信提醒、图表提醒和长期医嘱。
为了实施有效的疫苗接种计划,需要提高孕期推荐疫苗的接种率。需要一个孕产妇免疫接种平台,使产科护理提供者的疫苗接种做法常态化,并得到基础和继续教育、沟通策略以及广泛研究的支持。